Greenwich Biosciences, Inc.
Registered Principal Details
Business Or Interest:
Pharmaceutical manufacturing and healthcare
Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries
CEO Name:
Justin Gover
US General Counsel and Compliance Officer
Pharmaceutical manufacturing and healthcare
Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries
CEO Name:
Justin Gover
US General Counsel and Compliance Officer
Contact
AR
Angelique Rowley
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
(415) 610-7604
greenwichbio@politicomlaw.com
http://www.greenwichbiosciences.com
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
(415) 610-7604
greenwichbio@politicomlaw.com
http://www.greenwichbiosciences.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 49
Relating to: definition of tetrahydrocannabinols and the use of cannabidiol.
Bill Text and History
2/8/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: definition of tetrahydrocannabinols and the use of cannabidiol.
Bill Text and History
Other
Notification Date2/8/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 183
Relating to: growing and processing industrial hemp, granting rule-making authority, and making an appropriation. (FE)
Bill Text and History
10/16/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: growing and processing industrial hemp, granting rule-making authority, and making an appropriation. (FE)
Bill Text and History
None
Notification Date10/16/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 10
Relating to: definition of tetrahydrocannabinols and the use of cannabidiol.
Bill Text and History
2017 Wisconsin Act 4
2/8/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: definition of tetrahydrocannabinols and the use of cannabidiol.
Bill Text and History
2017 Wisconsin Act 4
Other
Notification Date2/8/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 119
Relating to: growing and processing industrial hemp, granting rule-making authority, and making an appropriation. (FE)
Bill Text and History
2017 Wisconsin Act 100
10/16/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: growing and processing industrial hemp, granting rule-making authority, and making an appropriation. (FE)
Bill Text and History
2017 Wisconsin Act 100
None
Notification Date10/16/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Any legislation or rule that impacts access to Epidiolex or its successor name, or cannabidiol in a drug product approved by the United States Food and Drug Administration.
Development, drafting or introduction of a proposal relating to
Any legislation or rule that impacts access to Epidiolex or its successor name, or cannabidiol in a drug product approved by the United States Food and Drug Administration.
Any legislation or rule that impacts access to Epidiolex or its successor name, or cannabidiol in a drug product approved by the United States Food and Drug Administration.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/18/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/18/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2017 January - June $27,000.00 |
2017 July - December $28,376.43 |
2018 January - June $27,000.00 |
2018 July - December $28,002.00 |
Total $110,378.43 |
| Total Hours Communicating | 2017 January - June 7.50 |
2017 July - December 7.50 |
2018 January - June 2.25 |
2018 July - December 1.75 |
Total 19.00 |
| Total Hours Other | 2017 January - June 25.75 |
2017 July - December 31.00 |
2018 January - June 15.50 |
2018 July - December 46.25 |
Total 118.50 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: definition of tetrahydrocannabinols and the use of cannabidiol.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 30% |
2017 July - December |
2018 January - June |
2018 July - December |
Total 7% |
Relating to: definition of tetrahydrocannabinols and the use of cannabidiol.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 50% |
2017 July - December |
2018 January - June |
2018 July - December |
Total 12% |
Relating to: growing and processing industrial hemp, granting rule-making authority, and making an appropriation. (FE)
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 15% |
2018 January - June |
2018 July - December |
Total 4% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
Any legislation or rule that impacts access to Epidiolex or its successor name, or cannabidiol in a drug product approved by the United States Food and Drug Administration.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 20% |
2017 July - December 70% |
2018 January - June 90% |
2018 July - December 60% |
Total 57% |
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication